Latin America Pharmaceutical Logistics Market: Forecast Analysis 2024-2032

Latin America Pharmaceutical Logistics Market: Forecast Analysis 2024-2032



According to Triton’s report, the Latin America pharmaceutical logistics market is estimated to advance with a CAGR of 7.01% during the forecast years 2024-2032.

The pharmaceutical distribution industry in Latin America is notably fragmented, comprising numerous small companies. Identifying a reliable distributor remains a significant challenge for pharmaceutical firms, necessitating a meticulous screening process. Despite these challenges, the region’s robust industry makes it an attractive market for ambitious pharmaceutical manufacturers and logistics companies. Besides, players from the US and Europe are keen to expand their reach in the region. For instance, DHL Supply Chain expanded its footprint in Mexico by acquiring New Transport Applications (NTA), a specialist in pharmaceutical and healthcare logistics, in 2022. Hence, such developments support the growth of the pharmaceutical logistics market.

Brazil leads the pharmaceutical logistics market, obtaining $2596.25 million in 2023

As Brazil imports around 95% of the raw materials for medicine production, fluctuations in freight costs and the rising dollar have escalated production expenses. This surge in costs has led to significant price increases for finished pharmaceutical products.

In response to these challenges, Brazil implemented a national medicines reverse logistics system (MRLS) in 2020 to ensure the proper disposal and potential reuse of medicines. This initiative complements existing local systems that have been in place since 2002, though there is no integration between the national and local systems.

According to the World Bank, Brazil allocates about 10.31% of its GDP to healthcare. Moreover, pharmaceutical exports reached approximately $1.1 billion in 2021. This increased spending on drugs and vaccines is fueling the expansion of the pharmaceutical logistics market.

Market Forecast for Mexico

According to the National Chamber of the Pharmaceutical Industry of Mexico, pharmaceutical production in Mexico saw around 36% increase in 2022, marking the first instance of double-digit growth in a decade. Additionally, the nation’s pharmaceutical industry has made impressive strides in export capabilities. In 2023, Mexico exported 165 out of the 350 critical pharmaceutical and active pharmaceutical ingredient (API) products identified by the International Trade Administration to the United States. Hence, all these developments are creating lucrative opportunities for pharmaceutical logistics companies to a large extent.

The market is branched into component, logistics type, therapy area, and pharma type. The component section further includes storage, monitoring components, and transportation.

The storage segment is a vital component of the pharmaceutical logistics market, comprising primarily warehouses and refrigerated containers. Warehouses serve as central hubs in the pharmaceutical supply chain, facilitating the efficient distribution of products. By connecting pharmaceutical manufacturers with healthcare providers, warehouses ensure the effective and secure distribution of medical goods. A heightened focus on the proper storage of temperature-sensitive supplements drives the growth of the storage segment.

The notable companies thriving in the pharmaceutical logistics market comprise Medline Industries LP, Kuehne + Nagel, Marken (Acquired by UPS), SEKO Logistics, and United Parcel Service (UPS).

Medline Industries LP, the largest privately-owned distributor and manufacturer of medical supplies, offers a diverse range of products, support services, and educational resources across the healthcare sector. Medline’s core team comprises clinicians, researchers, engineers, financial experts, and over 1,200 direct sales representatives. Headquartered in Northfield, Illinois, Medline has evolved into a leading supplier of clinical solutions and medical products, serving clients across multiple regions, including Latin America.

Latest from the Market:

In March 2024, Maersk collaborated with PUMA for the first semi-automated omni channel fulfillment distribution center in Chile.


1. Latin America Pharmaceutical Logistics Market - Summary
2. Industry Outlook
2.1. Impact Analysis On The Pharmaceutical Logistics Market
2.1.1. Impact Of Covid-19
2.2. Porter’s Five Forces Analysis
2.2.1. Threat Of New Entrants
2.2.2. Threat Of Substitutes
2.2.3. Bargaining Power Of Buyers
2.2.4. Bargaining Power Of Suppliers
2.2.5. Competitive Rivalry
2.3. Key Buying Impact Analysis
2.3.1. Logistics Type
2.3.2. Services Offered
2.3.3. Mode Of Transportation
2.3.4. Application
2.3.5. Regulatory Compliance
2.3.6. Technological Capabilities
2.3.7. Cost
2.3.8. Reliability
2.3.9. Agility
2.4. Value Chain Analysis
2.4.1. Manufacturing
2.4.2. Storage
2.4.3. Transportation
2.4.4. Distribution
2.4.5. Monitoring Components
2.4.6. Consumption
2.5. Regulatory Outlook
2.6. Market Attractiveness Index
2.7. Key Market Strategies
2.7.1. Contracts & Partnerships
2.7.2. Business Expansions & Divestitures
2.7.3. Acquisitions & Mergers
2.7.4. Product Launches & Developments
2.8. Market Drivers
2.8.1. Escalating Demand For Temperature-regulated Solutions
2.8.2. Expanding Ocean Freight Services
2.8.3. Increasing Consumer Inclination Towards Over-the-counter Medications
2.9. Market Challenges
2.9.1. Necessity For Real-time Transparency And Dependability
2.9.2. Stringent Regulatory Mandates
2.10. Market Opportunities
2.10.1. Rising Opportunities In Cell & Gene Therapy Logistics Due To Increased Demand
2.10.2. Digital Transformation Paving The Way For Advancements In Pharmaceutical Logistics
2.10.3. Growing Demand For Clinical Trial Logistics
2.11. Analyst Perspective
3. Latin America Pharmaceutical Logistics Market - By Component
3.1. Storage
3.2. Transportation
3.3. Monitoring Components
4. Latin America Pharmaceutical Logistics Market - By Pharma Type
4.1. Branded Drugs
4.2. Generic Drugs
4.3. Otc
5. Latin America Pharmaceutical Logistics Market - By Logistics Type
5.1. Non-cold Chain Logistics
5.2. Cold Chain Logistics
6. Latin America Pharmaceutical Logistics Market - By Therapy Area
6.1. Communicable Diseases
6.2. Oncology
6.3. Diabetes
6.4. Cardiovascular Diseases
6.5. Autoimmune Diseases
6.6. Neurological Disorders
6.7. Pain Management
6.8. Respiratory Diseases
6.9. Other Therapy Areas
7. Latin America Pharmaceutical Logistics Market – By Country Outlook
7.1. Brazil
7.1.1. Brazil Pharmaceutical Logistics Market Forecast & Prospects
7.2. Mexico
7.2.1. Mexico Pharmaceutical Logistics Market Forecast & Prospects
7.3. Rest Of Latin America
7.3.1. Rest Of Latin America Pharmaceutical Logistics Market Forecast & Prospects
8. Competitive Landscape
8.1. Agility Logistics
8.1.1. Overview
8.1.2. Portfolio
8.1.3. Key Strengths
8.1.4. Key Challenges
8.2. Ap Moller – Maersk
8.2.1. Overview
8.2.2. Portfolio
8.2.3. Key Strengths
8.2.4. Key Challenges
8.3. Cardinal Health Inc
8.3.1. Overview
8.3.2. Portfolio
8.3.3. Key Strengths
8.3.4. Key Challenges
8.4. Cencora (Amerisourcebergen)
8.4.1. Overview
8.4.2. Portfolio
8.4.3. Key Strengths
8.4.4. Key Challenges
8.5. Ceva Logistics
8.5.1. Overview
8.5.2. Portfolio
8.5.3. Key Strengths
8.5.4. Key Challenges
8.6. Db Schenker
8.6.1. Overview
8.6.2. Portfolio
8.6.3. Key Strengths
8.6.4. Key Challenges
8.7. Deutsche Post Ag
8.7.1. Overview
8.7.2. Portfolio
8.7.3. Key Strengths
8.7.4. Key Challenges
8.8. Dsv
8.8.1. Overview
8.8.2. Portfolio
8.8.3. Key Strengths
8.8.4. Key Challenges
8.9. Fedex Corporation
8.9.1. Overview
8.9.2. Portfolio
8.9.3. Key Strengths
8.9.4. Key Challenges
8.10. Kuehne + Nagel
8.10.1. Overview
8.10.2. Portfolio
8.10.3. Key Strengths
8.10.4. Key Challenges
8.11. Marken (Acquired By Ups)
8.11.1. Overview
8.11.2. Portfolio
8.11.3. Key Strengths
8.11.4. 8key Challenges
8.12. Medline Industries Lp
8.12.1. Overview
8.12.2. Portfolio
8.12.3. Key Strengths
8.12.4. Key Challenges
8.13. Seko Logistics
8.13.1. Overview
8.13.2. Portfolio
8.13.3. Key Strengths
8.13.4. Key Challenges
8.14. United Parcel Service (Ups)
8.14.1. Overview
8.14.2. Portfolio
8.14.3. Key Strengths
8.14.4. Key Challenges
9. Research Methodology & Scope
9.1. Research Scope & Deliverables
9.2. Sources Of Data
9.3. Research Methodology
List Of Tables
Table 1: Latin America Pharmaceutical Logistics Market, By Country Outlook, Historical Years, 2020-2023 (In $ Million)
Table 2: Latin America Pharmaceutical Logistics Market, By Country Outlook, Forecast Years, 2024-2032 (In $ Million)
Table 3: List Of Contracts & Partnerships
Table 4: List Of Business Expansions & Divestitures
Table 5: List Of Acquisitions & Mergers
Table 6: List Of New Product Launches & Developments
Table 7: Latin America Pharmaceutical Logistics Market, By Component, 2024-2032 (In $ Million)
Table 8: Latin America Pharmaceutical Logistics Market, By Pharma Type, 2024-2032 (In $ Million)
Table 9: Latin America Pharmaceutical Logistics Market, By Logistics Type, 2024-2032 (In $ Million)
Table 10: Latin America Pharmaceutical Logistics Market, By Therapy Area, 2024-2032 (In $ Million)
Table 11: Latin America Pharmaceutical Logistics Market, By Country Outlook, 2024-2032 (In $ Million)
List Of Figures
Figure 1: Porter’s Five Forces Analysis
Figure 2: Key Buying Impact Analysis
Figure 3: Value Chain Analysis
Figure 4: Latin America Pharmaceutical Logistics Market, By Component, 2023 & 2032 (In %)
Figure 5: Latin America Pharmaceutical Logistics Market, By Storage, 2024-2032 (In $ Million)
Figure 6: Latin America Pharmaceutical Logistics Market, By Transportation, 2024-2032 (In $ Million)
Figure 7: Latin America Pharmaceutical Logistics Market, By Monitoring Components, 2024-2032 (In $ Million)
Figure 8: Latin America Pharmaceutical Logistics Market, By Pharma Type, 2023 & 2032 (In %)
Figure 9: Latin America Pharmaceutical Logistics Market, By Branded Drugs, 2024-2032 (In $ Million)
Figure 10: Latin America Pharmaceutical Logistics Market, By Generic Drugs, 2024-2032 (In $ Million)
Figure 11: Latin America Pharmaceutical Logistics Market, By Otc, 2024-2032 (In $ Million)
Figure 12: Latin America Pharmaceutical Logistics Market, By Logistics Type, 2023 & 2032 (In %)
Figure 13: Latin America Pharmaceutical Logistics Market, By Non-cold Chain Logistics, 2024-2032 (In $ Million)
Figure 14: Latin America Pharmaceutical Logistics Market, By Cold Chain Logistics, 2024-2032 (In $ Million)
Figure 15: Latin America Pharmaceutical Logistics Market, By Therapy Area, 2023 & 2032 (In %)
Figure 16: Latin America Pharmaceutical Logistics Market, By Communicable Diseases, 2024-2032 (In $ Million)
Figure 17: Latin America Pharmaceutical Logistics Market, By Oncology, 2024-2032 (In $ Million)
Figure 18: Latin America Pharmaceutical Logistics Market, By Diabetes, 2024-2032 (In $ Million)
Figure 19: Latin America Pharmaceutical Logistics Market, By Cardiovascular Diseases, 2024-2032 (In $ Million)
Figure 20: Latin America Pharmaceutical Logistics Market, By Autoimmune Diseases, 2024-2032 (In $ Million)
Figure 21: Latin America Pharmaceutical Logistics Market, By Neurological Disorders, 2024-2032 (In $ Million)
Figure 22: Latin America Pharmaceutical Logistics Market, By Pain Management, 2024-2032 (In $ Million)
Figure 23: Latin America Pharmaceutical Logistics Market, By Respiratory Diseases, 2024-2032 (In $ Million)
Figure 24: Latin America Pharmaceutical Logistics Market, By Other Therapy Areas, 2024-2032 (In $ Million)
Figure 25: Latin America Pharmaceutical Logistics Market, By Country Outlook, 2023 & 2032 (In %)
Figure 26: Brazil Pharmaceutical Logistics Market 2024-2032 (In $ Million)
Figure 27: Mexico Pharmaceutical Logistics Market 2024-2032 (In $ Million)
Figure 28: Rest Of Latin America Pharmaceutical Logistics Market 2024-2032 (In $ Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings